Home / GFAP Knockout Cell Lines

GFAP Knockout Cell Lines

Gene: GFAP

Official Full Name: glial fibrillary acidic proteinprovided by HGNC

Gene Summary: This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO11302 GFAP Knockout cell line (HEK293) Human GFAP 1:3~1:6 Negative Online Inquiry
KO11303 GFAP Knockout cell line (A549) Human GFAP 1:3~1:4 Negative Online Inquiry

Background

GFAP Gene Knockout Cell Lines are genetically engineered cell models designed to specifically lack the expression of the Glial Fibrillary Acidic Protein (GFAP), a key intermediate filament protein predominantly expressed in astrocytes. This product serves as a valuable tool in studying astrocyte biology, neuroinflammation, and neurodegenerative diseases where GFAP plays a pivotal role in glial cell function and central nervous system pathology.

The mechanism of action of these knockout cell lines centers around CRISPR/Cas9 technology, which enables precise gene editing, effectively disrupting the GFAP gene. By creating a cellular environment devoid of this protein, researchers can elucidate the specific contributions of GFAP in various physiological and pathological processes. The absence of GFAP allows for the exploration of alterations in glial function, interactions with neurons, and the consequent effects on neurodevelopment and neural responses to injury.

The scientific importance of GFAP Gene Knockout Cell Lines cannot be overstated. These unique models provide an essential framework for investigating a wide array of conditions, including Alzheimer's disease, multiple sclerosis, and traumatic brain injury. In clinical settings, they are invaluable for screening potential therapeutics aimed at modulating glial responses and repairing neuroinflammation-related damage.

When compared to other cell line models, GFAP Gene Knockout Cell Lines outperform by providing a more accurate depiction of GFAP-deficient scenarios, significantly enhancing experimental outcomes. This specificity allows for a clearer interpretation of molecular pathways involved in astrocyte physiology and pathology, making them an indispensable resource for researchers and clinicians alike.

Our company prides itself on delivering high-quality biological products, rooted in rigorous scientific methodology and innovation. With a commitment to advancing research and understanding in cellular and molecular biology, our GFAP Gene Knockout Cell Lines are not only a testament to our expertise but a gateway for unlocking new avenues in neurological research.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.